FDA Inspection
Osmotica Pharmaceutical US LLCOsmotica Pharmaceutical US LLC – FDA Inspection, May 2, 2025
Record Details
This FDA Inspection record concerns Osmotica Pharmaceutical US LLC, with an inspection on May 2, 2025, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · bcd0928c-95f3-424a-ba3c-e4700c64ce58
Inspection Facts
- Inspection number
- 1268708
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Osmotica Pharmaceutical US LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 7, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Osmotica Pharmaceutical US LLC
- FDA Inspection 1102661 - 2019-08-07
- FDA Inspection 1076582 - 2019-01-18
- FDA Inspection 950789 - 2015-11-12
- FDA Inspection 830426 - 2013-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.